Search

everythinglearnresearchcommunity

for

Search:↓

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

PCOS in teens is hard to diagnose, linked to genetics and lifestyle, and managed with weight loss and medication.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Adult female acne requires a comprehensive treatment approach, including medical options and lifestyle changes, with attention to psychological well-being.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

Certain hormone treatments can improve acne and related conditions in women.

Early adrenal gland maturation in young children can be normal, but other serious conditions should be ruled out first.

Menopause affects hair and skin; more research needed for treatment.

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

Obesity increases the risk of skin infections, inflammatory conditions, and melanoma, but not basal cell carcinoma.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

The conclusion is that proper evaluation and treatment of hair loss in midlife women is important, considering the emotional impact and potential for various treatments.

Women with female-pattern baldness produce more testosterone, but 5a-reductase inhibition treatment won't help.

Hair loss in postmenopausal woman caused by ovarian issue.

Healthcare providers need better education and policies to serve transgender individuals effectively.

A postmenopausal woman's hirsutism and high testosterone levels improved after surgery for an ovarian tumor not seen on ultrasound.

Children with classic congenital adrenal hyperplasia have thicker heart fat and are at higher risk for heart problems and early atherosclerosis.

A woman's male-like symptoms and high testosterone were due to ovarian hilus-cell hyperplasia, which improved after surgery.

Hirsutism in women is often due to hormone sensitivity and has significant psychological effects.

Hirsutism causes significant psychological distress in women.

The document concludes that early diagnosis is key for treating common baldness in women, but reassurance is often the best approach as hair thinning can be a normal part of aging.

Different growth patterns in thyroid tumors are influenced by where cell growth and death occur.

Dr. Vera H. Price's 1979 work emphasizes the importance of accurate diagnosis and personalized treatment for hair loss.

Certain gene variations might be linked to severe acne in women but not in men.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.